Skip to main content
. 1997 Apr 7;185(7):1153–1162. doi: 10.1084/jem.185.7.1153

Table 2.

Grouping of Patient Isolate env Clones within pCR3 Based upon Restriction Digests and Choice of Predominant Clones for Preparation of vv

Patient Age Group Env clones* Recombinant vv
VI-05 2 mo 05-2M-A 3-2, 3-4, 3-5, 3-7, 3-8, 3-10 vvVI-05-2M
05-2M-B 3-3
6 mo 05-6M-A 4-2, 4-4, 4-5, 4-6, 4-8, 4-9 vvVI-05-6M
VI-06 Birth (1 d) 06-1D-A 1-2, 1-3
06-1D-B 1-9
06-1D-C 1-11, 1-12, 1-13, 1-15, 1-20 vvVI-06-ID
06-1D-D 1-18
6 mo 06-6M-A 2-1, 2-2, 2-3, 2-4, 2-7, 2-8, 2-9, 2-10
06-6M-B 2-5
VI-08 20 d 08-20D-A 5-4
08-20D-B 5-6
08-20D-C 5-2, 5-3, 5-8, 5-9, 5-10 vvVI-08-20D
6 mo 08-6M-A 6-1
08-6M-B 6-2, 6-3, 6-4, 6-7, 6-8, 6-9, 6-10 vvVI-08-6M
VI-11 1 mo 11-1M-A 7-1
11-1M-B 7-2, 7-5, 7-7, 7-10, 7-11, 7-16, 7-19 vvVI-11-1M
11-1M-C 7-12
3 mo 11-3M-A 8-3
11-3M-B 8-4, 8-11, 8-14, 8-16 vvVI-11-3M
*

 env genes amplified by PCR and ligated into pCR3 (InVitrogen); clones chosen for preparation of vv are in bold type.  

 vv not made from this time point due to instability of the env insert.